Jacqueline Allen
Psychiatric/Mental Health · Hazard, KYNPI 1730578121
Payments from drug & device makers
Across 160 payments — averaging $15.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$387
- Johnson & Johnson$312
- Alkermes, Inc.$309
- Axsome Therapeutics, Inc.$248
- Takeda Pharmaceuticals U.S.A., Inc.$199
- Corium, LLC$184
- plus $813 from 15 others
What the payments were for
- Food & beverage$2,40598%
- Education$472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $387 |
| Johnson & Johnson | 19 | $312 |
| Alkermes, Inc. | 21 | $309 |
| Axsome Therapeutics, Inc. | 8 | $248 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $199 |
| Corium, LLC | 15 | $184 |
| Otsuka America Pharmaceutical, Inc. | 11 | $182 |
| Ironshore Pharmaceuticals Inc. | 9 | $143 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $116 |
| E.r. Squibb & Sons, L.L.C. | 4 | $88 |
| Novo Nordisk | 4 | $64 |
| Tris Pharma Inc | 2 | $33 |
| Lundbeck LLC | 2 | $31 |
| Esperion Therapeutics, Inc. | 2 | $28 |
| Idorsia Pharmaceuticals US Inc | 1 | $25 |
| Sunovion Pharmaceuticals Inc. | 1 | $25 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Bayer | 1 | $16 |
| Novartis | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$125
How this compares
$2,452 in reported general payments places this provider in the 75th percentile of 946 psychiatric/mental health providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 184 | $257,043 |
| XifaxanRifaximin | 53 | $144,362 |
| SpravatoEsketamine Hcl | 102 | $100,918 |
| Invega SustennaPaliperidone Palmitate | 31 | $94,226 |
| TrintellixVortioxetine Hydrobromide | 192 | $82,411 |
| LybalviOlanzapine/Samidorphan Malate | 45 | $68,952 |
| RexultiBrexpiprazole | 21 | $39,821 |
| AuvelityDextromethorphan Hbr/Bupropion | 34 | $27,633 |
| MounjaroTirzepatide | 17 | $18,278 |
| BelsomraSuvorexant | 38 | $16,782 |
| Paliperidone ErPaliperidone | 28 | $14,041 |
| Nurtec OdtRimegepant Sulfate | 12 | $11,273 |
| Aimovig AutoinjectorErenumab-Aooe | 11 | $10,692 |
| QuviviqDaridorexant Hcl | 22 | $10,591 |
| Aripiprazole | 98 | $9,200 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $387 | $257,043184 claims |
| Johnson & JohnsonSpravato, Invega Sustenna | $312 | $195,144133 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $199 | $82,411192 claims |
| Alkermes, Inc.Lybalvi | $309 | $68,95245 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $182 | $39,82121 claims |
| Axsome Therapeutics, Inc.Auvelity | $248 | $27,63334 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $25 | $10,59122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 946 psychiatric/mental health providers in Kentucky.
Other psychiatric/mental health in Hazard
- Theresa WattsAshland$645K
- Rachel ColeHopkinsville$503K
- Denise de AngelisLouisville$384K
- Jennifer SampangCrestview Hills$322K
- Jeremy FisherSouth Shore$197K
- Jessica EstesLewisport$175K
- Christopher MulloneyNancy$95K
- Davika MattoxMorehead$79K
- Molly LutzCrestview Hills$71K
- Hope SmithHopkinsville$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.